Progressive loss in kidney function over a period of months or years.
1Patients: 1628 patients with chronic kidney disease participating in the MDRD Study.
2Summary: Transplant recipients are a unique group of chronic kidney disease patients.
3The trial enrolled 121 patients with moderate to severe chronic kidney disease.
4These factors increase inflammation, oxidative stress, and progression of chronic kidney disease.
5For example, how well is chronic kidney disease being managed at the moment?
6His medical history included common variable immunodeficiency and chronic kidney disease.
7Globally, an estimated 500 million people have chronic kidney disease, the researchers note.
8Disordered calcium balance and homeostasis are common in patients with chronic kidney disease.
9Over time, elevated sugar in the bloodstream can lead to chronic kidney disease.
10The disorder may lead to chronic kidney disease in many patients.
11Background: Elevated serum urate levels are associated with progression of chronic kidney disease.
12Dietary protein restriction is an important treatment for chronic kidney disease.
13However, the influence of CHOP on chronic kidney disease-correlated renal fibrosis remains unclear.
14The mTOR deregulation has a role in chronic kidney disease including diabetic nephropathy.
15There are few data on the association of AMD with chronic kidney disease.
16In its early stages, chronic kidney disease usually has no symptoms.
Translations for chronic kidney disease